Use of organic compound for the treatment of noonan syndrome

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

GU JESSIE

申请号：

NZ62054212

公开号：

NZ620542A

申请日:

2012.08.29

申请国别(地区):

NZ

年份:

2014

代理人:

摘要：

Disclosed is the use of MEK inhibitor compound 6-(4-bromo-2-fluorophenylamino)-7-fluro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide of Formula (I) for the preparation of a medicament for the treatment of Noonan Syndrome. Also disclosed is a method of treating a warm-blooded non-human animal having Noonan Syndrome, comprising administering to said non animal a therapeutically effective amount of a MEK inhibitor compound of Formula (I).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/